Lorukafusp alfa
- Generic Name
- Lorukafusp alfa
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2131168-99-3
- Unique Ingredient Identifier
- PL21OR4LXE
- Background
Lorukafusp alfa is under investigation in clinical trial NCT01334515 (Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma).
- Associated Conditions
- -
- Associated Therapies
- -
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed
Article references on neuroblastoma treatments, including advances in therapy, risk classification, and immunotherapy, with focus on NK cell-based strategies and clinical trials.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath